Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial  |
Reference |
Staphylococcus epidermidis (methicillin-resistant) |
0.13 |
0.25 |
0.13 - 2 |
Daptomycin (Cubicin)  |
7 |
Staphylococcus epidermidis (methicillin-resistant) |
0.2 |
0.39 |
0.2 - 3.13 |
Levofloxacin (Levaquin, Quixin)  |
17 |
Staphylococcus epidermidis (methicillin-resistant) |
0.25 |
0.25 |
0.03 - 1 |
Sparfloxacin (AT-4140, Zagam)  |
374 |
Staphylococcus epidermidis (methicillin-resistant) |
0.25 |
0.5 |
<0.008 - 2 |
Clinafloxacin (PD 127391)  |
12 |
Staphylococcus epidermidis (methicillin-resistant) |
0.25 |
0.5 |
0.125 - 1 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
248 |
Staphylococcus epidermidis (methicillin-resistant) |
0.25 |
0.5 |
0.125 - 1 |
SM-216601  |
115 |
Staphylococcus epidermidis (methicillin-resistant) |
0.25 |
16 |
0.125 - 32 |
Imipenem  |
115 |
Staphylococcus epidermidis (methicillin-resistant) |
0.39 |
0.39 |
0.2 - 3.13 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
17 |
Staphylococcus epidermidis (methicillin-resistant) |
0.5 |
0.5 |
0.25 - 0.5 |
SCH27899  |
129 |
Staphylococcus epidermidis (methicillin-resistant) |
0.5 |
0.5 |
0.25 - 1 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
374 |
Staphylococcus epidermidis (methicillin-resistant) |
0.5 |
64 |
0.063 - >128 |
Imipenem  |
600 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
1 |
≤0.25 - 1 |
Linezolid (PNU-100766, U-100766, Zyvox)  |
186 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
1 |
0.5 - 1 |
Linezolid (PNU-100766, U-100766, Zyvox)  |
115 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
1 |
0.5 - 2 |
Vancomycin (Vancocyn, Lyphocin)  |
7 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
1 |
1 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
115 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
1 |
1 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
115 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
1 |
11 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
1060 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
2 |
<0.008 - 16 |
Moxifloxacin (BAY 12-8039, Avelox)  |
12 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
2 |
0.015 - 16 |
Gatifloxacin (Tequin)  |
12 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
2 |
0.25 - 4 |
LY 191145  |
51 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
2 |
0.25 - 4 |
Minocycline (Minocycline hydrochloride, Minocin)  |
410 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
2 |
0.5 - 2 |
Vancomycin (Vancocyn, Lyphocin)  |
11 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
2 |
0.5 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox)  |
11 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
2 |
1 - 16 |
Linezolid (PNU-100766, U-100766, Zyvox)  |
1060 |
Staphylococcus epidermidis (methicillin-resistant) |
1 |
4 |
<0.008 - 16 |
Trovafloxacin (Trovan)  |
12 |
Staphylococcus epidermidis (methicillin-resistant) |
2 |
2 |
0.5 - 4 |
Chloroeremomycin (LY264826, A-82846B)  |
51 |
Staphylococcus epidermidis (methicillin-resistant) |
2 |
2 |
1 - 2 |
GSQ1530  |
1060 |
Staphylococcus epidermidis (methicillin-resistant) |
2 |
4 |
0.03 - 16 |
Garenoxacin (T-3811, BMS-284756)  |
102 |